BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tavares LP, Melo EM, Sousa LP, Teixeira MM. Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7). Semin Immunol 2022;59:101601. [PMID: 35219595 DOI: 10.1016/j.smim.2022.101601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Perretti M, Subramanian M. Resolution pharmacology - A fresh approach to the clinical management of human inflammatory diseases. Semin Immunol 2023;65:101669. [PMID: 36565567 DOI: 10.1016/j.smim.2022.101669] [Reference Citation Analysis]
2 Sugimoto MA, Perucci LO, Tavares LP, Teixeira MM, Sousa LP. Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation. Curr Drug Targets 2022;23:1578-92. [PMID: 36221881 DOI: 10.2174/1389450123666221011102250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]